Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
calcium chloride + sodium chloride + dextrose monohydrate + magnesium chloride + sodium
- Development stage
- Approved
- Lead developer
- Takeda
- Modality
- Small Molecules
- Administration
- Intraperitoneal
01
Overview
This is a non-specific multi-electrolyte and dextrose peritoneal dialysis solution description rather than a uniquely identifiable drug product. Dextrose creates an osmotic gradient across the peritoneal membrane to promote ultrafiltration and removal of excess fluid, while the electrolyte constituents help establish a dialysate composition appropriate for peritoneal dialysis. The incomplete final ingredient designation, \"sodium,\" does not specify the sodium salt or buffer and prevents unambiguous assignment to a specific marketed formulation. Closely related labeled products include DELFLEX, which contains dextrose monohydrate, sodium chloride, sodium lactate, calcium chloride, and magnesium chloride and is indicated for chronic kidney failure managed with peritoneal dialysis. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bbc5b820-4973-11e2-a192-0002a5d5c51b))
- Other names
- calcium chloride + sodium chloride + dextrose monohydrate + magnesium chloride + sodium
Beyond the preview
Go deeper on calcium chloride + sodium chloride + dextrose monohydrate + magnesium chloride + sodium.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on calcium chloride + sodium chloride + dextrose monohydrate + magnesium chloride + sodium.